GlaxoSmithKline to Market Non-Profit Meningitis Vaccine in Africa

Europe’s biggest drug company has announced it is taking the first steps towards marketing a vaccine in Africa from which it never expects to make money. GlaxoSmithKline says it has begun filing documents with the regulatory authorities concerning its meningitis vaccine called Globorix